Discover ITT Inc.'s growth in revenue and profits, current valuation, and future outlook. Click for why a Hold rating is ...

Diversified operations rebound as MMM, ITT, and STRR capitalize on aerospace, defense, industrial growth, innovation, and ...

(NYSE: ITT) today announced that its KONI business, a leading designer and manufacturer of advanced shock absorption ...

Exelixis stock dips after Phase 3 data show modest survival gains from zanzalintinib and Tecentriq combo in colorectal cancer ...

ITT Inc. (NYSE: ITT) will release its third quarter 2025 financial results before the opening of the New York Stock Exchange ...

Advocates and lawmakers introduced the Accountability for For-Profit Colleges bill package on Oct. 15, 2025, during a press ...

Summit Therapeutics is aggressively pursuing U.S. approval for ivonescimab in NSCLC, despite lacking statistically ...

Buying $100 In ITT: If an investor had bought $100 of ITT stock 5 years ago, it would be worth $267.35 today based on a price of $170.97 for ITT at the time of writing.

EDINBURG, Pa. (MyValleyTributes) – Phillips Charles Reed, 72, of Edinburg, passed away early Saturday morning, October 18, ...

Most recurrent ovarian cancer cases arise in patients previously treated with PARP inhibitors making these results noteworthy ...

WTM London to convene largest number of global leaders at this year’s Ministers’ Summit.

US biotech Exelixis has announced detailed results from STELLAR-303, a global Phase III pivotal trial evaluating ...